UNIVERSITY OF TX MD ANDERSON CAN CTR
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer is a funding opportunity from UNIVERSITY OF TX MD ANDERSON CAN CTR, up to 441654, closing July 31, 2028.
Jul 31, 2028
(732d left)Overview
Project Summary/Abstract Venous thromboembolism (VTE) develops in about one-fourth of patients with ovarian cancer and is associated with significant morbidity and mortality. Chemotherapy increases VTE risk, but administration of prophylactic anticoagulation to all patients on chemotherapy is associated with a…